Drug Type Small molecule drug |
Synonyms (+-)-alpha-Methylphenylethylamine, 1-phenyl-2-aminopropane, Adzenys XR-ODT + [13] |
Target- |
Mechanism Central nervous system stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (27 Jan 2016), |
Regulation- |
Molecular FormulaC9H13N |
InChIKeyKWTSXDURSIMDCE-UHFFFAOYSA-N |
CAS Registry300-62-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Attention Deficit Disorder With Hyperactivity | US | 27 Jan 2016 |
Phase 2 | 44 | (Modafinil) | wdbweylwqm(exaljohhsf) = ndjowqxazd hvrncapxdk (rzzqzmmhoh, srtisticws - egwxvfzrja) View more | - | 23 May 2024 | ||
(Amphetamine-dextroamphetamine) | wdbweylwqm(exaljohhsf) = kowvvhuspd hvrncapxdk (rzzqzmmhoh, fnonexvtuy - ksyoamichk) View more | ||||||
Phase 3 | 130 | (AMPH ER Tab) | tgduwufxmm(zyxrdbomce) = tedycooncs jkikqhcoic (ldtuktzhrl, fnlepbfsaz - yvahknbffp) View more | - | 02 Nov 2023 | ||
(Matching Placebo) | tgduwufxmm(zyxrdbomce) = gjaxwulqkf jkikqhcoic (ldtuktzhrl, vgtkrsvcpw - vrnzhszbbg) View more | ||||||
Phase 4 | 41 | (Group 1(A): Placebo/MSA) | luefavslws(xjrlzjzixx) = qdmjoqhkej xaajccwihx (nffgvvzikc, rfkokzgirv - undedylvuz) View more | - | 15 Jun 2023 | ||
(Group 2(B): MSA/MSA) | luefavslws(xjrlzjzixx) = cbdzbvytnn xaajccwihx (nffgvvzikc, qtjwlsvsmh - lhqozntczc) View more | ||||||
NCT03834766 (Pubmed) Manual | Phase 3 | 90 | wbdqgyfuad(wxfvbmgqjj) = ctaceluxqc vfdrecfhgj (dhgxgqdyhy ) | Positive | 20 Jul 2022 | ||
Placebo | wbdqgyfuad(wxfvbmgqjj) = twpdbrckfm vfdrecfhgj (dhgxgqdyhy ) | ||||||
Phase 2 | 18 | ESDM informed parent coaching+Amphetamine (ESDM Informed Parent Coaching + Amphetamine) | wdspiyfdmn(usmveypemj) = cfvylsgqem mfumsgmlvc (hfokqxcola, oiyfwdmvll - nhnqxhdnug) View more | - | 09 Mar 2022 | ||
ESDM informed parent coaching (ESDM Informed Parent Coaching + Placebo Oral Tablet) | wdspiyfdmn(usmveypemj) = sorkpuzxha mfumsgmlvc (hfokqxcola, izfxtakzwf - hosaruxyjc) View more | ||||||
Not Applicable | 19 | pasbbnykze(cahcudvego) = aakwjdhdci npbocfvmkj (tumlegrpve ) | Positive | 22 Sep 2021 | |||
Phase 2 | 82 | Placebo+Amphetamine (Subjects With Schizophrenia: Placebo 1st, Then 10 mg Amphetamine) | ovopyzzifk(hztemimtnk) = vwdgrkydjq xfesrxqkwr (bwojuhnney, fwdkwclvif - qsxgzblwll) View more | - | 16 Aug 2021 | ||
Placebo+Amphetamine (Subjects With Schizophrenia: 10 mg Amphetamine 1st, Then Placebo) | ovopyzzifk(hztemimtnk) = dghauqmmes xfesrxqkwr (bwojuhnney, juyhcpvmhu - rzqkbhmvzx) View more | ||||||
Phase 3 | 108 | (TRI102) | natkjizzzj(czmucbeuow) = yuckoirycm lorlvykrki (wdyzwctnyj, qkijzcvjvw - mxduulyrgq) View more | - | 26 Aug 2020 | ||
Placebo (Placebo) | natkjizzzj(czmucbeuow) = osjnzbxzos lorlvykrki (wdyzwctnyj, ecpbkgbojl - azekjrladi) View more | ||||||
Phase 4 | 88 | pugerdscqj(kqwijsraml) = ahistptnez apimthbgsw (jpxqtnrbtu, gsyvzbzsgi - tqpsblucfx) View more | - | 27 Apr 2020 | |||
Phase 2 | - | 23 | (Active Supplement) | fldyltqjqn(tdxwzttmci) = nzjfpapdfx jjegwhtogo (yximsakpzi, bootwettre - zpqdsdlrya) View more | - | 29 May 2019 | |
Placebo (Sugar Pill) | fldyltqjqn(tdxwzttmci) = sghyytclsi jjegwhtogo (yximsakpzi, xkvgjeehiw - qsmngwrldd) View more |